Corporate Announcement Of Omkar Speciality Chemicals Ltd.
Intimation of the board meeting 01.06.2017
Intimation of the board meeting 14.11.2016
Intimation of the board meeting
Voting Results for 11th Annual General Meeting
Proceedings of 11th Annual General Meeting
Newspaper Notice of 11th AGM, Book Closure & Evoting
Intimation of Conference Call On 17.08.2016
Intimation of Conference Call On 19.07.2016
Press Release - 17.25 Lakh Shares Sold by Promoters
Purchase of Plot of Land by Lasa Laboratory Private Limited
Intimation of Conference Call On 25.05.2016
Outcome of Board Meeting Held on 23.05.2016
Intimation of Conference Call On 12.04.2016
Outcome of Board Meeting Held on 28.03.2016
Intimation of Incorporation of a Wholly Owned Subsidiary Company 12.03.2016
Transcript of Earnings Conference Call On 15.02.2016
Intimation of Conference Call On 15.02.1016
Intimation of Board Meeting
Regulation 30 - Disclosure of Event(Revision in rating) 15.12.2015
Omkar Speciality Chemicals Limited (OSCL) is pleased to inform that, Mr. Pravin S. Herlekar, Promoter and Chairman & Managing Director of OSCL has been honored for his dedicated services to the Chemical Industry and developing various molecules through research and development activity in this field, by Free Press Journal group, at the hands of Mr. Devendra Fadnavis, Chief Minister of State of Maharashtra, in the presence of Hon’ble Shri Ram Naik, Governor of State of Uttar Pradesh, on 30th April, 2015.
Omkar Speciality Chemicals Ltd Bags Concrete Indents Worth Rs 100 Crore
Omkar Speciality Chemicals Limited (OSCL), a manufacturer of Intermediates and Active Pharmaceuticals Ingredients (APIs), is fully geared up with the help of its existing capacities to take care of the market demands during the current Year.
With its newly developed products and also various approvals received from its customers, the Company has received concrete indents in the month of April, 2015, from its customers in India as well as from different geographies, worth close to Rs.100 crores to be executed during the Current Financial Year.
Omkar Speciality Chemicals Limited (including its wholly owned subsidiaries) has 9 Units in the State of Maharashtra, India (5 Units in Badlapur, Dist: Thane, 3 Units in Chiplun, Dist: Ratnagiri and 1 Unit in Mahad, Dist: Raigad) with a total volumetric installed capacity of 4920 MTPA.
We wish to inform you that, our Company’s claim for process patent for an Advance Intermediate namely “BENZENESELENINIC ANHYDRIDE”, having special applications in pharmaceutical industry has been accepted by the Patents Office, Govt. of India, vide their Certificate No. 022/11999 Patent Registration No. 263298 dated 17th October, 2014.
We wish to submit for the information to all concerned that, our wholly owned subsidiary, M/s. Lasa Laboratory Private Limited, has been successful in obtaining the Certificate of Suitability from European Directorate for the Quality of Medicines & Healthcare (EDQM), vide certificate No. R0-CEP 2013-184-Rev 00 dated 15th October, 2014, for selling its product “FENBENDAZOLE”.
This certificate will be useful for the Company in marketing its above product to regulatory customers in the European Market for Veterinary use.
Omkar Speciality Chemicals Limited is pleased to invite the Shareholders of the Company, to visit its Plants located in the vicinity of Badlapur on Saturday, 1st November, 2014. This Plant visit is a half day program and is limited for 100 people. Shareholders who are interested can make reservation by sending an email at email@example.com on or before 20th October, 2014.
We wish to inform you that, our Company’s claim for process patent for an Advance Intermediate namely “5-IODO-2-METHYLBENZOIC ACID”, having special applications in pharmaceutical industry has been accepted by the Patents Office, Govt. of India, vide their Certificate No. 022/11015 Patent Registration No. 262739 dated 10th September, 2014.
Omkar Speciality Chemicals Ltd. is pleased to announce that the Shareholding of the Promoter’s Group has been increased from 11,858,816 shares (60.42%) as on 30th September, 2013 to 12,569,080 shares (64.04%) as on 15th November, 2013, through secondary market acquisitions.
Further, it is our privilege that, IDFC Premier Equity Fund (Mutual Fund) has acquired 880,510 shares (4.49%) of the Company in the recent past, from the secondary market.
Commissioning of Our New Facility at Urdhwa Chemicals Co. Pvt. Ltd. (Wholly Owned Subsidiary), Chiplun
'There are no events, information or price sensitive information that the Company is withholding which may have a bearing on the operations or performance of the Company and which the Company ought to make to the Stock Exchanges as required under Clause 36 of the Listing Agreement.
Also, we are unaware of the cause of price volatility in our script and recent increase in the volume of trading."
|Board Meeting||Annual General Meeting||Extra Ordinary General Meeting||Postal Ballot|
|2015-16||26.09.2015||14.02.2013||20.11.2014 - 20.12.2014|
|2014-15||03.08.2014 - 03.09.2014|